Conyers advises on $350m privatisation of 3SBio Inc
Conyers Dill & Pearman has acted as Cayman counsel to the Buyer Group — 3SBio chairman and chief executive officer Jing Lou and CITIC Private Equity Funds Management – in the privatisation of 3SBio Inc by way of merger.
3SBio is a China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products. Its shareholders are entitled to $2.38-per-share in cash or $16.70 per American Depositary Share.
Conyers partner David Lamb from the law firm’s Hong Kong office advised on Cayman law and worked alongside Skadden, Arps, Slate, Meagher & Flom LLP and Akin Gump Strauss Hauer & Feld LLP.
News from Conyers Dill & Pearman
Briefings from Conyers Dill & Pearman
Modern company, partnership, trust, and other related laws have made Bermuda a leading offshore financial centre for the formation of private equity vehicles.
FATCA imposes due diligence, information reporting and control burdens on a range of non-US financial intermediaries and investment entities.